Heparan sulphate glycosaminoglycans in the glomerular filtration barrier

Heparan sulphate glycosaminoglycans in the glomerular filtration barrier - HS GAG in the glomerular filtration barrier

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON42338

Enrollment

Registered

2015-07-14

Start date

2015-09-03

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple osteochondromas

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Subjects should be over 18 years of age and capacitated.

Exclusion criteria

Exclusion criteria: No confirmed mutation status in either the EXT1 or EXT2 gene

Design outcomes

Primary

Measure	Time frame
The main study parameters are the differences in proportion of subjects with micro-albuminuria, urinary albumin/creatinine ratio, and the difference in perfused boundary region between patients and controls.	—

Countries

Netherlands

Outcome results